{"symbol":"LLY","fiscalQuarter":"Q2-2023","reportDate":"2023-08-08","reportTime":"BMO","status":"reported","company":{"name":"Eli Lilly and Company","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/LLY/earnings/Q2-2023","postBrief":{"headline":"Eli Lilly Beats on EPS, Stock Up 14.87%","keyNumbers":[{"metric":"EPS","actual":"$2.11","expected":"N/A","surprise":"+6.57%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record for the earnings call, and the analysis is based solely on numerical results."},"guidanceChanges":{"summary":"No guidance data is available for this quarter.","changes":[]},"whatItMeans":"Eli Lilly's earnings report showed a positive surprise in EPS, which likely contributed to the stock's significant increase of nearly 15%. Investors may be encouraged by the company's performance, even though revenue details were not disclosed. The lack of guidance may leave some uncertainty about future performance.","metaDescription":"Eli Lilly (LLY) Q2 2023 earnings: EPS beat by 6.57%. Stock up 14.87%. Full breakdown."}}